Stem Cell Therapy Market - Size & Share Report, 2032

Stem Cell Therapy Market - By Type (Allogenic Stem Cell Therapy, Autologous Stem Cell Therapy), By Therapeutic Area (Oncology, Orthopedic, Cardiovascular, Neurology), End-use (Hospitals, Clinics) & Global Forecast, 2023-2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Methodology

1.2&nbsp;&nbsp;&nbsp; Market scope and definition

1.3&nbsp;&nbsp;&nbsp; Base estimates and working

1.4&nbsp;&nbsp;&nbsp; Forecast parameters

1.5&nbsp;&nbsp;&nbsp; COVID-19 impact analysis at global level

1.6&nbsp;&nbsp;&nbsp; Data validation

1.7&nbsp;&nbsp;&nbsp; Data sources

1.7.1&nbsp;&nbsp;&nbsp; Primary

1.7.2&nbsp;&nbsp;&nbsp; Secondary

1.7.2.1&nbsp;&nbsp;&nbsp;Paid sources

1.7.2.2&nbsp;&nbsp;&nbsp;Unpaid sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Stem cell therapy industry 3600 synopsis, 2018 - 2032

2.1.1&nbsp;&nbsp;&nbsp; Business trends

2.1.2&nbsp;&nbsp;&nbsp; Type trends

2.1.3&nbsp;&nbsp;&nbsp; Therapeutic area trends

2.1.4&nbsp;&nbsp;&nbsp; End-use trends

2.1.5&nbsp;&nbsp;&nbsp; Regional trends

Chapter 3&nbsp;&nbsp;&nbsp;Stem Cell Therapy Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry segmentation

3.2&nbsp;&nbsp;&nbsp; Industry landscape, 2018 - 2032

3.3&nbsp;&nbsp;&nbsp; Industry impact forces

3.3.1&nbsp;&nbsp;&nbsp; Growth drivers

3.3.1.1&nbsp;&nbsp;&nbsp;Advancements in regenerative medicine in North America &amp; Europe

3.3.1.2&nbsp;&nbsp;&nbsp;Increasing government initiatives for stem cell therapy in developed as well as developing countries

3.3.1.3&nbsp;&nbsp;&nbsp;Rising awareness regarding availability of stem cell therapy in developing countries

3.3.1.4&nbsp;&nbsp;&nbsp;Growing prevalence of chronic diseases

3.3.1.5&nbsp;&nbsp;&nbsp;Increasing research and development activities undertaken by companies for stem cell therapy

3.3.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.3.2.1&nbsp;&nbsp;&nbsp;High cost of stem cell therapy

3.3.2.2&nbsp;&nbsp;&nbsp;Ethical issues associated with stem cell therapy

3.4&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4.1&nbsp;&nbsp;&nbsp; By type

3.4.2&nbsp;&nbsp;&nbsp; By therapeutic area

3.4.3&nbsp;&nbsp;&nbsp; By end-use

3.5&nbsp;&nbsp;&nbsp; COVID-19 impact analysis

3.6&nbsp;&nbsp;&nbsp; Stem cell therapy ecosystem analysis

3.7&nbsp;&nbsp;&nbsp; Regulatory landscape

3.7.1&nbsp;&nbsp;&nbsp; U.S.

3.7.2&nbsp;&nbsp;&nbsp; Europe

3.7.3&nbsp;&nbsp;&nbsp; Asia Pacific

3.8&nbsp;&nbsp;&nbsp; Stem cell source

3.8.1&nbsp;&nbsp;&nbsp; Mesenchymal stem cells (MSCs)

3.8.2&nbsp;&nbsp;&nbsp; Hematopoietic stem cells (HSCs)

3.8.3&nbsp;&nbsp;&nbsp; Embryonic stem cells (ESCs)

3.8.4&nbsp;&nbsp;&nbsp; Induced pluripotent stem cells (iPSCs)

3.9&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.10&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis

4.3&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.4&nbsp;&nbsp;&nbsp; Strategy dashboard

Chapter 5&nbsp;&nbsp;&nbsp;Stem Cell Therapy Market, By Type

5.1&nbsp;&nbsp;&nbsp; Key type trends

5.2&nbsp;&nbsp;&nbsp; Allogenic stem cell therapy

5.2.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

5.3&nbsp;&nbsp;&nbsp; Autologous stem cell therapy

5.3.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 6&nbsp;&nbsp;&nbsp;Stem Cell Therapy Market, By Therapeutic Area

6.1&nbsp;&nbsp;&nbsp; Key therapeutic area trends

6.2&nbsp;&nbsp;&nbsp; Oncology

6.2.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

6.3&nbsp;&nbsp;&nbsp; Orthopedic

6.3.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

6.4&nbsp;&nbsp;&nbsp; Cardiovascular

6.4.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

6.5&nbsp;&nbsp;&nbsp; Neurology

6.5.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

6.6&nbsp;&nbsp;&nbsp; Orthopedic

6.6.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7&nbsp;&nbsp;&nbsp;Stem Cell Therapy Market, By End-use

7.1&nbsp;&nbsp;&nbsp; Key end-use trends

7.2&nbsp;&nbsp;&nbsp; Hospitals

7.2.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

7.3&nbsp;&nbsp;&nbsp; Clinics

7.3.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

7.4&nbsp;&nbsp;&nbsp; Orthopedic

7.4.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 8&nbsp;&nbsp;&nbsp;Stem Cell Therapy Market, By Region

8.1&nbsp;&nbsp;&nbsp; Key regional trends

8.2&nbsp;&nbsp;&nbsp; North America

8.2.1&nbsp;&nbsp;&nbsp; U.S.

8.2.2&nbsp;&nbsp;&nbsp; Canada

8.3&nbsp;&nbsp;&nbsp; Europe

8.3.1&nbsp;&nbsp;&nbsp; Germany

8.3.2&nbsp;&nbsp;&nbsp; UK

8.3.3&nbsp;&nbsp;&nbsp; France

8.3.4&nbsp;&nbsp;&nbsp; Spain

8.3.5&nbsp;&nbsp;&nbsp; Italy

8.3.6&nbsp;&nbsp;&nbsp; Russia

8.3.7&nbsp;&nbsp;&nbsp; Poland

8.3.8&nbsp;&nbsp;&nbsp; Switzerland

8.3.9&nbsp;&nbsp;&nbsp; Netherlands

8.4&nbsp;&nbsp;&nbsp; Asia Pacific

8.4.1&nbsp;&nbsp;&nbsp; Japan

8.4.2&nbsp;&nbsp;&nbsp; China

8.4.3&nbsp;&nbsp;&nbsp; India

8.4.4&nbsp;&nbsp;&nbsp; Australia

8.4.5&nbsp;&nbsp;&nbsp; South Korea

8.4.6&nbsp;&nbsp;&nbsp; Thailand

8.4.7&nbsp;&nbsp;&nbsp; Singapore

8.5&nbsp;&nbsp;&nbsp; Latin America

8.5.1&nbsp;&nbsp;&nbsp; Brazil

8.5.2&nbsp;&nbsp;&nbsp; Argentina

8.5.3&nbsp;&nbsp;&nbsp; Mexico

8.5.4&nbsp;&nbsp;&nbsp; Chile

8.6&nbsp;&nbsp;&nbsp; Middle East &amp; Africa

8.6.1&nbsp;&nbsp;&nbsp; South Africa

8.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

8.6.3&nbsp;&nbsp;&nbsp; UAE

8.6.4&nbsp;&nbsp;&nbsp; Israel

Chapter 9&nbsp;&nbsp;&nbsp;Company Profiles

9.1&nbsp;&nbsp;&nbsp; Astellas Pharma Inc

9.2&nbsp;&nbsp;&nbsp; CHIESI Farmaceutici S.p.A.

9.3&nbsp;&nbsp;&nbsp; Capricor Therapeutics

9.4&nbsp;&nbsp;&nbsp; Cellectis

9.5&nbsp;&nbsp;&nbsp; Fujifilm Cellular Dynamics

9.6&nbsp;&nbsp;&nbsp; GSK plc.

9.7&nbsp;&nbsp;&nbsp; ThermoGenesis Holdings, Inc

9.8&nbsp;&nbsp;&nbsp; DiscGenics

9.9&nbsp;&nbsp;&nbsp; Mesoblast Ltd

9.10&nbsp;&nbsp;&nbsp; Novadip Biosciences

9.11&nbsp;&nbsp;&nbsp; MEDIPOST

9.12&nbsp;&nbsp;&nbsp; Takeda Pharmaceuticals

9.13&nbsp;&nbsp;&nbsp; Celyad

9.14&nbsp;&nbsp;&nbsp; Gamida Cell

9.15&nbsp;&nbsp;&nbsp; ReNeuron Group plc 
&nbsp;

Stem Cell Therapy Market

Get a free sample of this report